<?xml version="1.0" encoding="UTF-8"?>
<p>In the context of 
 <bold>Ebolavirus</bold> vaccines, LNP-encapsulated modified mRNA encoding EBOV GP delivered IM was shown to induce EBOV-specific IgG and neutralizing antibody responses and protected guinea pigs against lethal infection and signs of clinical illness (
 <xref rid="B175" ref-type="bibr">175</xref>). However, no clinical studies employing mRNA vaccines in the context of Ebola virus have been initiated.
</p>
